BRPI0412190A - sólidos com camada de difusão modulada - Google Patents

sólidos com camada de difusão modulada

Info

Publication number
BRPI0412190A
BRPI0412190A BRPI0412190-2A BRPI0412190A BRPI0412190A BR PI0412190 A BRPI0412190 A BR PI0412190A BR PI0412190 A BRPI0412190 A BR PI0412190A BR PI0412190 A BRPI0412190 A BR PI0412190A
Authority
BR
Brazil
Prior art keywords
diffusion layer
modulated
solids
drug
poorly soluble
Prior art date
Application number
BRPI0412190-2A
Other languages
English (en)
Inventor
Michael Hawley
Walter Morozowich
Michael S Bergren
John W Skoug
Philip R Nixon
John M Heimlich
Ping Gao
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0412190A publication Critical patent/BRPI0412190A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SóLIDOS COM CAMADA DE DIFUSãO MODULADA". A presente invenção refere-se aos sólidos modulados pela cadeia de difusão, que incluam um excipiente e um sal solúvel de um fármaco básico e pouco solúvel; um sal solúvel de um fármaco ácido pouco solúvel; ou um fármaco não-ionizável e pouco solúvel, são úteis, por exemplo, para a melhoria da veiculação de fármacos.
BRPI0412190-2A 2003-07-01 2004-06-29 sólidos com camada de difusão modulada BRPI0412190A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48420503P 2003-07-01 2003-07-01
PCT/US2004/021143 WO2005004763A1 (en) 2003-07-01 2004-06-29 Diffusion layer modulated solids

Publications (1)

Publication Number Publication Date
BRPI0412190A true BRPI0412190A (pt) 2006-08-22

Family

ID=34062033

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412190-2A BRPI0412190A (pt) 2003-07-01 2004-06-29 sólidos com camada de difusão modulada

Country Status (9)

Country Link
US (1) US20050042291A1 (pt)
EP (1) EP1643948A1 (pt)
JP (1) JP2007527394A (pt)
AR (1) AR044983A1 (pt)
BR (1) BRPI0412190A (pt)
CA (1) CA2531116A1 (pt)
MX (1) MXPA06000178A (pt)
TW (1) TW200514576A (pt)
WO (1) WO2005004763A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060446A1 (fr) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Preparation medicamenteuse contenant du 5-methyle-1-phenyle-2-(1h)-pyridone en tant que principe actif
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
EP2555757B1 (en) * 2010-04-09 2016-05-25 Bristol-Myers Squibb Holdings Ireland Atazanavir sulfate formulations with improved ph effect
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
WO2013058303A1 (ja) * 2011-10-18 2013-04-25 ラクオリア創薬株式会社 医薬組成物
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP7454666B2 (ja) * 2019-11-12 2024-03-22 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 薬物コーティングされたバルーン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4028772A (en) * 1971-04-02 1973-09-27 Merck & Co., Inc Chemical processes
US4355091A (en) * 1980-08-25 1982-10-19 Polaroid Corporation Polymeric neutralizing layer with temporary crosslinks from an organo-metallic crosslinking agent
IT1255792B (it) * 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
ZA984514B (en) * 1997-05-29 1998-11-30 Merck & Co Inc Hiv protease inhibitor
DE69934582T2 (de) * 1998-06-11 2007-10-04 Pharmacia & Upjohn Co. Llc, Kalamazoo Delavirdin tablettenformulierung
ES2251985T3 (es) * 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
CN1402629A (zh) * 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
JP2004534812A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物

Also Published As

Publication number Publication date
EP1643948A1 (en) 2006-04-12
JP2007527394A (ja) 2007-09-27
US20050042291A1 (en) 2005-02-24
WO2005004763A1 (en) 2005-01-20
AR044983A1 (es) 2005-10-12
TW200514576A (en) 2005-05-01
CA2531116A1 (en) 2005-01-20
MXPA06000178A (es) 2006-04-11

Similar Documents

Publication Publication Date Title
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
ATE553780T1 (de) Ph-sensitives polymer
CY1107841T1 (el) Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
DE60007095T2 (de) Calanolide zur hemmung von btk
BRPI0508744A (pt) sistema de retenção gástrica e processo para revestir um comprimido ou cápsula
CY1113679T1 (el) Απταμερες εναντι midkine και χρηση αυτου
WO2007113648A3 (en) Ctla4 antibody combination therapy
BR0112104A (pt) Processos para tratamento de doenças reumáticas usando uma molécula de ctla4 solúvel
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
BRPI0702965A (pt) parte de sistema de implante dental
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
EP1706128A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INSULIN TREATMENT
BRPI0516577A (pt) agentes terapêuticos com toxicidade diminuìda
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0412190A (pt) sólidos com camada de difusão modulada
MA29481B1 (fr) Derives d'azolopyridine-2-one en tant qu'inhibiteurs de lipase et de phospholipase
BRPI0620229A8 (pt) formulação
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
ATE478156T1 (de) Verfahren zur identifizierung von modulatoren der eoxin-bildung
ATE485261T1 (de) Salicylsäurederivate
DK1602669T3 (da) Antistof mod et tumor-specifikt antigen som target
BRPI0516922A (pt) composto de ribavirina, método para fazer um composto de ribavirina, método para usar um composto de ribavirina e composição farmacêutica
MY140530A (en) Antineoplasic compounds and pharmaceuticals compositions thereof
BR0317425A (pt) Sal de rabeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.